Ticker Details
CASI Pharmaceuticals, Inc. CASI Pharmaceuticals Inc is engaged in research and development of biopharmaceutical products. It mainly focuses on acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs.
IPO Date:	July 1, 1996
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$15.82M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 3.92%
Avg Daily Range (30 D):	$0.04 | 3.77%
Avg Daily Range (90 D):	$0.05 | 4.31%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.03M
Avg Daily Volume (90 D):	.03M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	162
Avg Trade Size (Sh.) (90 D):	180

Institutional Trades
Total Institutional Trades:	33
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$2.95M
Avg Institutional Trade (90 D):	$2.95M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.69M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	94.73K

News

Jun 27, 2024 @ 1:42 PM CASI Pharmaceuticals (CASI) Up on Buyout Offer for... Source: Zacks Equity Research

Nov 15, 2023 @ 5:00 PM HC Wainwright & Co. Maintains Buy Rating for CASI ... Source: Benzinga Insights

Oct 24, 2023 @ 9:30 PM USANA Health Sciences (USNA) Q3 Earnings Miss Esti... Source: Zacks Equity Research

Oct 11, 2023 @ 12:24 PM Why VOXX International Shares Are Trading Higher B... Source: Lisa Levin

Aug 10, 2023 @ 2:04 PM Ionis Pharmaceuticals (IONS) Q2 Earnings and Reven... Source: Zacks Equity Research

Financials
	TTM	Q2 2022	Q1 2022
Basic EPS	$-.38	$-.56	$-.06
Diluted EPS	$-.38	$-.56	$-.06
Revenue	$10.21M	$8.57M	$9.06M
Gross Profit	$5.97M	$5.02M	$5.3M
Net Income / Loss	$-5.02M	$-7.49M	$-8.4M
Operating Income / Loss	$-6.35M	$-7.75M	$-7.29M
Cost of Revenue	$4.25M	$3.55M	$3.76M
Net Cash Flow	$18.97M	$-9.52M	$-9.45M
PE Ratio

Splits
Jun 02, 2022	1:10
Jul 01, 2010	1:11